HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meeting report VLPNPV: Session 3: Immune responses.

Abstract
Virus-like particles (VLPs) and nano-particles (NP) are increasingly considered for both prophylactic and therapeutic vaccines for a wide variety of human and animal diseases. Indeed, 2 VLPs have already been licensed for use in humans, the human papilloma virus vaccine and the hepatitis B virus vaccine. (1) Reflecting this increased interest, a second international conference with a specific focus on VLPs and NP was held at the Salk Institute for Biological Studies in La Jolla, California, in June 2014. Approximately 100 attendees, hailing from many nations, came from academic institutions, research institutes, and biotech companies. A wide variety of topics were discussed, ranging from development and characterization of specific VLP and NP vaccine candidates to methods of production of these particles. Session three was focused on the general question of immune responses to VLPs.
AuthorsTrudy G Morrison
JournalHuman vaccines & immunotherapeutics (Hum Vaccin Immunother) Vol. 10 Issue 10 Pg. 3064-7 ( 2014) ISSN: 2164-554X [Electronic] United States
PMID25529229 (Publication Type: Congress)
Chemical References
  • Antibodies, Viral
  • Antigens, Viral
  • Hepatitis B Vaccines
  • Papillomavirus Vaccines
  • Vaccines, Virus-Like Particle
Topics
  • Animals
  • Antibodies, Viral
  • Antigens, Viral (immunology)
  • Caliciviridae (immunology)
  • Hepatitis B Vaccines (immunology, therapeutic use)
  • Humans
  • Immunization
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Nanoparticles
  • Papillomavirus Vaccines (immunology, therapeutic use)
  • Vaccines, Virus-Like Particle (immunology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: